QQQ   444.60 (+1.28%)
AAPL   178.49 (-1.25%)
MSFT   414.15 (+0.12%)
META   501.13 (+2.24%)
GOOGL   137.99 (-0.34%)
AMZN   178.03 (+0.72%)
TSLA   203.12 (+0.61%)
NVDA   818.42 (+3.45%)
NIO   5.82 (+1.22%)
AMD   200.69 (+4.24%)
BABA   74.74 (+0.96%)
T   16.96 (+0.18%)
F   12.42 (-0.16%)
MU   95.43 (+5.32%)
CGC   3.27 (-0.61%)
GE   159.08 (+1.40%)
DIS   111.76 (+0.16%)
AMC   4.41 (+2.08%)
PFE   26.58 (+0.08%)
PYPL   60.63 (+0.48%)
XOM   105.81 (+1.23%)
QQQ   444.60 (+1.28%)
AAPL   178.49 (-1.25%)
MSFT   414.15 (+0.12%)
META   501.13 (+2.24%)
GOOGL   137.99 (-0.34%)
AMZN   178.03 (+0.72%)
TSLA   203.12 (+0.61%)
NVDA   818.42 (+3.45%)
NIO   5.82 (+1.22%)
AMD   200.69 (+4.24%)
BABA   74.74 (+0.96%)
T   16.96 (+0.18%)
F   12.42 (-0.16%)
MU   95.43 (+5.32%)
CGC   3.27 (-0.61%)
GE   159.08 (+1.40%)
DIS   111.76 (+0.16%)
AMC   4.41 (+2.08%)
PFE   26.58 (+0.08%)
PYPL   60.63 (+0.48%)
XOM   105.81 (+1.23%)
QQQ   444.60 (+1.28%)
AAPL   178.49 (-1.25%)
MSFT   414.15 (+0.12%)
META   501.13 (+2.24%)
GOOGL   137.99 (-0.34%)
AMZN   178.03 (+0.72%)
TSLA   203.12 (+0.61%)
NVDA   818.42 (+3.45%)
NIO   5.82 (+1.22%)
AMD   200.69 (+4.24%)
BABA   74.74 (+0.96%)
T   16.96 (+0.18%)
F   12.42 (-0.16%)
MU   95.43 (+5.32%)
CGC   3.27 (-0.61%)
GE   159.08 (+1.40%)
DIS   111.76 (+0.16%)
AMC   4.41 (+2.08%)
PFE   26.58 (+0.08%)
PYPL   60.63 (+0.48%)
XOM   105.81 (+1.23%)
QQQ   444.60 (+1.28%)
AAPL   178.49 (-1.25%)
MSFT   414.15 (+0.12%)
META   501.13 (+2.24%)
GOOGL   137.99 (-0.34%)
AMZN   178.03 (+0.72%)
TSLA   203.12 (+0.61%)
NVDA   818.42 (+3.45%)
NIO   5.82 (+1.22%)
AMD   200.69 (+4.24%)
BABA   74.74 (+0.96%)
T   16.96 (+0.18%)
F   12.42 (-0.16%)
MU   95.43 (+5.32%)
CGC   3.27 (-0.61%)
GE   159.08 (+1.40%)
DIS   111.76 (+0.16%)
AMC   4.41 (+2.08%)
PFE   26.58 (+0.08%)
PYPL   60.63 (+0.48%)
XOM   105.81 (+1.23%)
OTCMKTS:HOCPY

HOYA (HOCPY) Stock Price, News & Analysis

$130.12
+4.21 (+3.34%)
(As of 02/29/2024 ET)
Today's Range
$129.67
$130.78
50-Day Range
$116.77
$130.48
52-Week Range
$95.04
$132.25
Volume
24,750 shs
Average Volume
53,639 shs
Market Capitalization
$45.67 billion
P/E Ratio
38.61
Dividend Yield
0.35%
Price Target
N/A

HOYA MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.01% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.30mentions of HOYA in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.72%
From $3.35 to $3.91 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.46 out of 5 stars


HOCPY stock logo

About HOYA Stock (OTCMKTS:HOCPY)

HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it engages in the research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. Additionally, the company offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke, a time and attendance management service, as well as Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

HOCPY Stock Price History

HOCPY Stock News Headlines

Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Hoya Corp.
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Hoya Corp ADR HOCPY
Hoya Capital
The Fed Disconnect
HOCPY.PK - | Stock Price & Latest News | Reuters
HOYA Corporation (HOCPY)
HOYA is about to announce its earnings — here's what to expect
See More Headlines
Receive HOCPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HOYA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Today
3/01/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:HOCPY
CIK
N/A
Fax
N/A
Employees
36,571
Year Founded
1941

Profitability

Net Income
$1.26 billion
Pretax Margin
28.45%

Debt

Sales & Book Value

Annual Sales
$5.36 billion
Cash Flow
$4.69 per share
Book Value
$16.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$45.67 billion
Optionable
Not Optionable
Beta
0.85

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Eiichiro Ikeda (Age 54)
    Representative Executive Officer, President, CEO & Chairperson of Board of Directors
    Comp: $1.3M
  • Mr. Ryo Hirooka (Age 50)
    Representative Executive Officer, CFO & Director
    Comp: $812.03k
  • Ms. Tomoko Nakagawa
    Executive Officer & Chief Sustainability (ESG) Officer
  • Taishi Arashida
    Officer of IR

Should I Buy HOYA Stock? HOCPY Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of HOYA was last updated on Sunday, February 25, 2024 at 3:21 PM.

Pros

Here are some ways that investors could benefit from investing in HOYA Co.:

  • HOYA Corporation is a med-tech company that provides high-tech and medical products worldwide, offering innovative solutions in the healthcare industry.
  • Recent developments include the introduction of new products such as Life Care, Telecommunications, and Information Technology services, showcasing the company's commitment to diversification and growth.
  • HOYA Corporation has a strong market presence and a long-standing history since its founding in 1941, indicating stability and reliability for investors.
  • The company's focus on technology and innovation, as seen in its electronic payslip service Yonosuke, demonstrates a forward-thinking approach that can lead to future success.
  • HOYA Corporation's headquarters in Tokyo, Japan, strategically positions it in a key market for technological advancements and healthcare innovations, offering potential for further expansion and partnerships.

Cons

Investors should be bearish about investing in HOYA Co. for these reasons:

  • While HOYA Corporation has a strong market presence, competition in the med-tech industry is fierce, and the company may face challenges in maintaining its competitive edge.
  • The company's reliance on technology and innovation for growth can also pose risks, as rapid advancements in the industry may require continuous investment and adaptation to stay ahead.
  • Market fluctuations and economic uncertainties can impact HOYA Corporation's performance, affecting investor confidence and stock prices.
  • Investors should carefully monitor financial metrics such as Net Margins, Return on Equity, and Return on Assets to assess the company's profitability and efficiency in generating returns.
  • Considering factors like Price-Earnings Ratio, Dividend Yield, and Market Cap can provide insights into HOYA Corporation's valuation and financial health, influencing investment decisions.














HOCPY Stock Analysis - Frequently Asked Questions

Should I buy or sell HOYA stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HOYA in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" HOCPY shares.
View HOCPY analyst ratings
or view top-rated stocks.

How have HOCPY shares performed in 2024?

HOYA's stock was trading at $124.52 on January 1st, 2024. Since then, HOCPY shares have increased by 4.5% and is now trading at $130.12.
View the best growth stocks for 2024 here
.

Are investors shorting HOYA?

HOYA saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 33,000 shares, an increase of 132.4% from the January 31st total of 14,200 shares. Based on an average trading volume of 174,300 shares, the short-interest ratio is currently 0.2 days.
View HOYA's Short Interest
.

How were HOYA's earnings last quarter?

HOYA Co. (OTCMKTS:HOCPY) posted its quarterly earnings data on Thursday, February, 1st. The technology company reported $0.75 EPS for the quarter, missing analysts' consensus estimates of $0.82 by $0.07. The technology company earned $1.36 billion during the quarter. HOYA had a net margin of 21.50% and a trailing twelve-month return on equity of 19.46%.

Is HOYA a good dividend stock?

HOYA (OTCMKTS:HOCPY) pays an annual dividend of $0.45 per share and currently has a dividend yield of 0.35%. The dividend payout ratio is 13.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HOCPY will have a dividend payout ratio of 11.51% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HOCPY.

How do I buy shares of HOYA?

Shares of HOCPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does HOYA have any subsidiaries?
The following companies are subsidiares of HOYA: DAEJEON DAEMYUNG OPTICAL (HANGZHOU) CO. LTD., HOEV CO. LTD., HOYA CORPORATION USA, HOYA ELECTRONICS KOREA CO. LTD., HOYA ELECTRONICS MALAYSIA SDN.BHD., HOYA ELECTRONICS SINGAPORE PTE. LTD., HOYA FINANCE B.V., HOYA GLASS DISK PHILIPPINES INC., HOYA GLASS DISK VIETNAM LTD., HOYA GLASS DISK VIETNAM Ⅱ LTD., HOYA HOLDINGS (ASIA) B.V., HOYA HOLDINGS ASIA PACIFIC PTE LTD, HOYA HOLDINGS INC., HOYA HOLDINGS N.V., HOYA LAMPHUN LTD., HOYA LENS AUSTRALIA PTY.LTD., HOYA LENS CANADA INC., HOYA LENS DEUTSCHLAND GMBH, HOYA LENS FRANCE S.A.S., HOYA LENS GUANGZHOU LTD., HOYA LENS IBERIA S.A., HOYA LENS INDIA PRIVATE LIMITED, HOYA LENS ITALIA S.P.A., HOYA LENS MANUFACTURING MALAYSIA SDN.BHD., HOYA LENS THAILAND LTD., HOYA LENS U.K. LTD., HOYA LENS VIETNAM LTD., HOYA MICROELECTRONICS TAIWAN CO. LTD., HOYA OPTICAL (ASIA) CO. LTD., HOYA OPTICAL LABS OF AMERICA INC., HOYA OPTICAL TECHNOLOGY (SUZHOU) LTD., HOYA OPTICAL TECHNOLOGY (WEIHAI) CO. LTD., HOYA OPTICS (THAILAND) LTD., HOYA OPTO-ELECTRONICS QINGDAO LTD., HOYA SURGICAL OPTICS INC., HOYA TURKEY OPTIK LENS SANAYI VE TICARET A.S., MICROLINE SURGICAL INC., PENTAX CANADA INC., PENTAX CEBU PHILIPPINES CORPORATION, PENTAX EUROPE GMBH, PENTAX ITALIA S.R.L, PENTAX MEDICAL (PENANG) SDN. BHD., PENTAX U.K. LTD., PERFORMANCE OPTICS KOREA LTD., and PT.VISION-EASE ASIA.
Read More
This page (OTCMKTS:HOCPY) was last updated on 3/1/2024 by MarketBeat.com Staff